Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Capital Employed (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Return on Capital Employed for 12 consecutive years, with 0.31% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 12.0% year-over-year to 0.31%, compared with a TTM value of 0.31% through Sep 2025, down 12.0%, and an annual FY2024 reading of 0.14%, up 15.0% over the prior year.
  • Return on Capital Employed was 0.31% for Q3 2025 at Tandem Diabetes Care, down from 0.31% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.04% in Q3 2021 and bottomed at 0.31% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.15%, with a median of 0.19% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -29bps in 2023, then rose 17bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.03% in 2021, then plummeted by -445bps to 0.1% in 2022, then crashed by -196bps to 0.31% in 2023, then soared by 55bps to 0.14% in 2024, then tumbled by -127bps to 0.31% in 2025.
  • Business Quant data shows Return on Capital Employed for TNDM at 0.31% in Q3 2025, 0.31% in Q2 2025, and 0.27% in Q1 2025.